Respero Myrtol (Capsules) Instructions for Use

ATC Code

R05CA10 (Expectorants in combination)

Active Substance

Mirtol (Grouping name)

Clinical-Pharmacological Group

Herbal preparation with expectorant effect

Pharmacotherapeutic Group

Herbal expectorant

Pharmacological Action

A herbal remedy that has expectorant, mucolytic, antimicrobial, fungicidal, antioxidant, and deodorizing effects.

By activating ciliary activity, it increases mucociliary clearance.

It reduces the viscosity of bronchial secretions by changing the pH and facilitates the removal of sputum by activating the activity of the ciliated epithelium.

Pharmacokinetics

It is well absorbed in the small intestine.

C_max in blood plasma is reached 1-3 hours after administration.

Approximately 60% of the active substance and its metabolites are excreted in the urine, 5% in the feces, and about 2% through the lungs.

It can cross the placental barrier and be excreted in breast milk.

Indications

As part of the complex therapy of inflammatory diseases of the respiratory tract (sinusitis, acute and chronic bronchitis).

ICD codes

Dosage Regimen

Administer orally. For adults and adolescents over 12 years, the standard dose is one 300 mg capsule taken three to four times daily.

For children aged 6 to 11 years, the dose is one 120 mg capsule taken three to four times daily.

Swallow the capsules whole with a sufficient amount of liquid, preferably before meals.

Do not chew or crush the capsules. The duration of treatment is determined by the physician based on the clinical presentation and severity of symptoms.

For acute conditions, continue treatment for several days after symptoms resolve. Do not exceed the recommended daily dosage.

Adverse Reactions

From the digestive system: frequently – stomach pain; sometimes: gastritis, gastroenteritis, nausea, vomiting, diarrhea, flatulence, dry mouth, taste change.

From the immune system: allergic reactions are possible (shortness of breath, facial swelling, rash, urticaria, itching, bronchospasm); unknown: severe anaphylactic reactions.

From the nervous system: headache, dizziness are possible.

From the urinary system: very rarely – increased mobility of existing kidney stones.

From the liver and biliary tract: very rarely – increased mobility of existing gallstones.

Contraindications

Hypersensitivity to the active substance, cholelithiasis, urolithiasis, bronchial asthma, first trimester of pregnancy, breastfeeding period, children under 6 years of age, liver diseases.

Use in Pregnancy and Lactation

Due to the lack of special studies in the second and third trimesters of pregnancy, use with caution as prescribed by a doctor, provided that the intended benefit to the mother outweighs the potential risk to the fetus.

Use during breastfeeding is contraindicated.

Pediatric Use

Prescribed to children according to indications.

Special Precautions

If after using this remedy the symptoms persist or worsen, or if shortness of breath, fever, purulent or bloody sputum appears, it is necessary to consult a doctor immediately.

In case of bronchial asthma, whooping cough, or other respiratory diseases associated with severe hypersensitivity of the airways, this remedy is used only after consultation with a doctor.

Drug Interactions

Should not be used simultaneously with drugs that have a narrow therapeutic index.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.